Junj Yang News Today

Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove challenging to treat, with survival among relapsed or resistant cases falling between 30-50%.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

The measure of total DNA in leukemic cells as defined by a DNA index outperformed other criteria for identifying patients with hyperdiploid acute lymphoblastic leukemia (ALL) and favorable prognosis.

Hyperdiploidy is a genetic condition observed in cancer cells, where the cells contain more chromosomes than usual.

Scientists at St. Jude Children's Research Hospital are reporting the most comprehensive study to date describing the variations in drug response across different genetic subtypes of acute lymphoblastic leukemia (ALL).

A study into drug response of genetic subtypes of ALL could provide a map to more precisely match available treatments to patients

Scientists have completed the largest study of families affected by Hodgkin lymphoma and identified novel variants linked to cancer predisposition.

Why did my child get cancer? Clinicians have longed for a way to help answer this question. Doctors knew Hodgkin lymphoma sometimes occurs in families, but why this happens has been a mystery. Scientists at St. Jude Children's Research Hospital have now helped solve it.

Jun J. Yang, Ph.D., St. Jude departments of Oncology and Pharmaceutical Sciences, is co-corresponding author of the new paper published in Nature

MEMPHIS, Tenn., Jan. 27, 2022 /PRNewswire/ -- Scientists at St. Jude Childrens Research Hospital are studying the impact of genetic ancestry on c...